These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6154464)

  • 1. Interactions of the glycopeptide antitumor antibiotics bleomycin and tallysomycin with deoxyribonucleic acid in vitro.
    Lown JW; Joshua AV
    Biochem Pharmacol; 1980 Feb; 29(4):521-32. PubMed ID: 6154464
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties and products of the degradation of DNA by bleomycin and iron(II).
    Sausville EA; Stein RW; Peisach J; Horwitz SB
    Biochemistry; 1978 Jul; 17(14):2746-54. PubMed ID: 80227
    [No Abstract]   [Full Text] [Related]  

  • 3. Catalytic release of deoxyribonucleic acid bases by oxidation and reduction of an iron.bleomycin complex.
    Povirk LF
    Biochemistry; 1979 Sep; 18(18):3989-95. PubMed ID: 90519
    [No Abstract]   [Full Text] [Related]  

  • 4. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycins A and B.
    Konishi M; Saito K; Numata K; Tsuno T; Asama K
    J Antibiot (Tokyo); 1977 Oct; 30(10):789-805. PubMed ID: 591444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. V. Production, characterization and antitumor activity of tallysomycin S10b, a new biosynthetic tallysomycin derivative.
    Miyaki T; Numata K; Nishiyama Y; Tenmyo O; Hatori M; Imanishi H; Konishi M; Kawaguchi H
    J Antibiot (Tokyo); 1981 Jun; 34(6):665-74. PubMed ID: 6168631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and DNA binding properties of novel bleomycin analogues.
    Xu ZD; Wang M; Xiao SL; Liu CL; Yang M
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2595-9. PubMed ID: 12852974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifunctional intercalation of antitumor antibiotics BBM-928A and echinomycin with deoxyribonucleic acid. Effects of intercalation on deoxyribonucleic acid degradative activity of bleomycin and phleomycin.
    Huang CH; Prestayko AW; Crooke ST
    Biochemistry; 1982 Jul; 21(15):3704-10. PubMed ID: 6180762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transition metal binding properties of a 3rd generation bleomycin analogue, tallysomycin.
    Greenaway FT; Dabrowiak JC; Van Husen M; Grulich R; Crooke ST
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1407-14. PubMed ID: 84672
    [No Abstract]   [Full Text] [Related]  

  • 9. A radioimmunoassay for tallysomycin.
    Broughton A; Strong JE; Crooke ST; Prestayko AW; Knight J
    Cancer Treat Rep; 1979; 63(11-12):1829-32. PubMed ID: 93510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. IV. New biosynthetic derivatives of tallysomycin.
    Miyaki T; Tenmyo O; Numata K; Matsumoto K; Yamamoto H; Nishiyama Y; Ohbayashi M; Imanishi H; Konishi M; Kawaguchi H
    J Antibiot (Tokyo); 1981 Jun; 34(6):658-64. PubMed ID: 6168630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production of hydroxyl radical from copper(I) complex systems of bleomycin and tallysomycin: comparison with copper(II) and iron(II) systems.
    Sugiura Y
    Biochem Biophys Res Commun; 1979 Sep; 90(1):375-83. PubMed ID: 91372
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of deoxyribonucleic acid on the production of reduced oxygen by bleomycin and iron.
    Caspary WJ; Lanzo DA; Niziak C
    Biochemistry; 1982 Jan; 21(2):334-8. PubMed ID: 6176260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. I. Production, isolation and properties.
    Kawaguchi H; Tsukiura H; Tomita K; Konishi M; Saito K
    J Antibiot (Tokyo); 1977 Oct; 30(10):779-88. PubMed ID: 591443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron--dioxygen-dependent changes to the biological activities of bleomycin.
    Gutteridge JM; Shute DJ
    J Inorg Biochem; 1981 Dec; 15(4):349-57. PubMed ID: 6172560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the interaction of bleomycin A2 with rat lung microsomes. II. Involvement of adventitious iron and reactive oxygen in bleomycin-mediated DNA chain breakage.
    Trush MA; Mimnaugh EG; Ginsburg E; Gram TE
    J Pharmacol Exp Ther; 1982 Apr; 221(1):159-65. PubMed ID: 7062279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of covalently closed circular deoxyribonucleic acid for prescreening for antitumor compounds.
    Mong S; Strong JE; Bush JA; Crooke ST
    Antimicrob Agents Chemother; 1979 Sep; 16(3):398-405. PubMed ID: 507796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of the biosynthetic gene clusters and pathways for three structurally related antitumor antibiotics: bleomycin, tallysomycin, and zorbamycin.
    Galm U; Wendt-Pienkowski E; Wang L; Huang SX; Unsin C; Tao M; Coughlin JM; Shen B
    J Nat Prod; 2011 Mar; 74(3):526-36. PubMed ID: 21210656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of bleomycin analogues with deoxyribonucleic acid and metal ions studied by fluorescence quenching.
    Huang CH; Galvan L; Crooke ST
    Biochemistry; 1980 Apr; 19(9):1761-7. PubMed ID: 6155142
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin.
    Kross J; Henner WD; Hecht SM; Haseltine WA
    Biochemistry; 1982 Aug; 21(18):4310-8. PubMed ID: 6181807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the effects of the antitumor agent camptothecin and derivatives on DNA. Camptothecin potentiated cleavage of DNA by bleomycin in vitro.
    Lown JW; Chen HH; Plambeck JA
    Chem Biol Interact; 1981 Apr; 35(1):55-70. PubMed ID: 6162579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.